An ACAT inhibitor suppresses SARS-CoV-2 replication and boosts antiviral T cell activity
Description
The severity of disease following infection with SARS-CoV-2 is determined by viral replication kinetics and host immunity, with early T cell responses and/or suppression of viraemia driving a favourable outcome. Recent studies uncovered a role for
